After the completion of a PhD in 2005, Mark was appointed the senior research scientist of the Queensland Institute of Medical Research arm of the Human Helminth Vaccine Initiative, a multi-national collaborative effort funded by the Bill and Melinda Gates Foundation to develop recombinant vaccines against the human parasitic worms, Necator americanus and Schistosoma mansoni.

In 2009, Mark was granted an NHMRC training fellowship to study how molecules in parasite secretions and on the parasite surface influence the host-parasite relationship with a view to develop anti-worm vaccines and novel therapies for autoimmune disorders. Mid-way through 2011 Mark completed part of this work at the Institute of Infection and Immunology Research at the University of Edinburgh and is now continuing this research at James Cook University.

Interests

Research

• Mark’s major research focus involves looking at the functions of proteins from human parasites (specifically helminths, or worms) and how these molecules interact with the host immune system.I am particularly interested in understanding these processes in the context of developing vaccines against parasites of third world populations and finding novel therapies for autoimmune disorders such as asthma.

Experience

• 2011 to present - Research Fellow, James Cook University (Cairns, Qld, Australia)
• 2009 to 2011 - Research Fellow, University of Edinburgh (Edinburgh, UK)
• 2006 to 2010 - Research Officer, Queensland institute of Medical Research (Brisbane, Qld, Australia)
• 2001 to 2005 - PhD Student, Queensland institute of Medical Research (Brisbane, Qld, Australia)

Research Disciplines

• Medical Microbiology (1108)
• Clinical Sciences (1103)

Socio-Economic Objectives

• Clinical Health (9201)
• Public Health (9204)

Awards

• 2011 - Finalist - Australian Museum Eureka Prizes
• 2010 - Research Australia Griffith University Discovery Award

Fellowships

• 2009 to 2013 - NHMRC Early Career Training Fellowship

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Singh A, McBride J, Govan B and Pearson M (2019) Survey of local fauna from endemic areas of northern Queensland, Australia for the presence of Mycobacterium ulcerans. International Journal Of Mycobacteriology, 8 (1). pp. 48-52
• Singh A, McBride W, Govan B, Pearson M and Ritchie S (2019) A survey on Mycobacterium ulcerans in mosquitoes and march flies captured from endemic areas of northern Queensland, Australia. PLoS Neglected Tropical Diseases, 13 (2).
• Wangchuk P, Kouremenos K, Eichenberger R, Pearson M, Susianto A, Wishart D, McConville M and Loukas A (2019) Metabolomic profling of the excretory–secretory products of hookworm and whipworm. Metabolomics, 15.
• Bouchery T, Filbey K, Shepherd A, Chandler J, Patel D, Schmidt A, Camberis M, Peignier A, Smith A, Johnston K, Painter G, Pearson M, Giacomin P, Loukas A, Bottazzi M, Hotez P and LeGros G (2018) A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development. PLoS Pathogens, 14 (3).
• Mekonnen G, Pearson M, Loukas A and Sotillo J (2018) Extracellular vesicles from parasitic helminths and their potential utility as vaccines. Expert Review of Vaccines, 17 (3). pp. 197-205
• Singh A, McBride W, Govan B and Pearson M (2018) Potential animal reservoir of Mycobacterium ulcerans: a systematic review. Tropical Medicine and Infectious Disease, 3 (2).
• Sundaraneedi M, Eichenberger R, Al-Hallaf R, Yang D, Sotillo J, Rajan S, Wangchuk P, Giacomin P, Keene F, Loukas A, Collins J and Pearson M (2018) Polypyridylruthenium(II) complexes exert in vitro and in vivo nematocidal activity and show significant inhibition of parasite acetylcholinesterases. International Journal for Parasitology: Drugs and Drugs Resistance, 8 (1). pp. 1-7
• Wendt G, Collins J, Pei J, Pearson M, Bennett H, Loukas A, Berriman M, Grishin N and Collins III J (2018) Flatworm-specific transcriptional regulators promote the specification of tegumental progenitors in Schistosoma mansoni. eLife, 7.
• Sundaraneedi M, Tedla B, Eichenberger R, Becker L, Pickering D, Smout M, Rajan S, Wangchuk P, Keene F, Loukas A, Collins J and Pearson M (2017) Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases. PLoS Neglected Tropical Diseases, 11 (12).
• Sundaraneedi M, Ammit A, Tedla B, Pearson M, Loukas A, Keene F and Collins J (2017) Tetranuclear polypyridylruthenium(II) complexes as inhibitors and down-regulators of phosphatase enzymes. ChemistrySelect, 2 (33). pp. 10668-10672
• Driguez P, Li Y, Gaze S, Pearson M, Nakajima R, Trieu A, Doolan D, Felgner P, Hou X, Cardoso F, Jasinskas A, Gobert G, Loukas A and McManus D (2016) Antibody signatures reflect different disease pathologies in patients with schistosomiasis due to Schistosoma japonicum. Journal of Infectious Diseases, 213 (1). pp. 122-130
• Driguez P, McWilliam H, Gaze S, Piedrafita D, Pearson M, Nakajima R, Duke M, Trieu A, Doolan D, Cardoso F, Jasinskas A, Gobert G, Felgner P, Loukas A, Meeusen E and McManus D (2016) Specific humoral response of hosts with variable schistosomiasis susceptibility. Immunology and Cell Biology, 94. pp. 52-65

More

ResearchOnline@JCU stores 50+ research outputs authored by Dr Mark Pearson from 2002 onwards.

Current and recent Research Funding to JCU is shown by funding source and project.

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

Current

• Characterisation of the proteomic composition of Schistosoma haematobium extracellular vesicles: towards the development of vaccine and diagnostic candidate antigens (PhD , Secondary Advisor)
• Schistosome exosomes - immunobiology and vaccine efficacy (PhD , Secondary Advisor)
• Rational Vaccine Development for Malaria from Genomic Sequence Information (PhD , Secondary Advisor)

Completed

• Targeting schistosome cholinesterases for vaccine and drug development (2019, PhD , Primary Advisor)
• Investigation of potential environmental reservoirs of mycobacterium ulcerans in North Queensland (2019, Masters , Secondary Advisor)
• Hookworm Na-ASP-2- Putative Functions, Allergenicity and Implications for Vaccine Development (2015, PhD , Associate Advisor)

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.